The bulk market for MSR sales has never been better, and that’s a bit of a problem. Activity is so robust that due diligence reviews are piling up, delaying deal closings. A good problem to have? It depends on your profit goals.
We pointed it out before, but the situation has not changed: Nonbanks that went public over the past 16 months are not doing well when it comes to share price. As for meaning: Such a performance does not bode well for other nonbanks contemplating life in the public realm.
Commercial banks cranked up the value of their servicing portfolios in the third quarter, but not dramatically. Soon, we’ll find out how the nonbanks viewed the same asset.
Profits (and profitability) drive the decision to sell a mortgage company. Several lender/servicers are at an inflection point or soon will be. In sum, the rest of 2021 should be interesting.